Open AccessAn EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect
Author(s) -
Farah Rahal,
Caroline Capdevielle,
Benoı̂t Rousseau,
Julien Izotte,
JeanWilliam Dupuy,
David Cappellen,
Guillaume Chotard,
Mélissa Ménard,
Justine Charpentier,
Vincent Jecko,
Charline Caumont,
É. Gimbert,
Christophe F. Grosset,
Martin Hagedorn
Publication year - 2022
Publication title -
neuro-oncology advances
Language(s) - English
Resource type - Journals
ISSN - 2632-2498
DOI - 10.1093/noajnl/vdac018
Subject(s) - in vivo , glioma , ezh2 , cancer research , apoptosis , cell culture , in vitro , chemistry , cell growth , biology , histone , biochemistry , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom